Aflac Honored as American Cancer Society's 2025 Corporate Partner of the Year
Event summary
- Aflac received the American Cancer Society's 2025 Corporate Partner of the Year award for its multimillion-dollar commitment and leadership in cancer advocacy.
- The partnership focuses on increasing cancer screenings, with Aflac's Check for Cancer movement aiming to raise awareness about early detection.
- Aflac's 2025 Wellness Matters Survey found that 90% of Americans have delayed health checkups despite the potential life-saving benefits of early cancer detection.
The big picture
Aflac's recognition underscores a growing trend of insurers aligning with healthcare organizations to address critical public health issues. The partnership highlights the strategic importance of early detection in cancer care, an area where Aflac aims to leverage its position as the leading provider of supplemental health insurance in the U.S.
What we're watching
- Impact of Awareness Campaigns
- How Aflac's Check for Cancer movement will affect cancer screening rates and early detection outcomes.
- Partnership Sustainability
- Whether Aflac can maintain its high level of engagement and financial commitment to the American Cancer Society in the long term.
- Market Differentiation
- The pace at which Aflac's focus on cancer advocacy will set it apart from competitors in the supplemental health insurance market.
Our editorial coverage:
Related topics